{"id":"inflammatory-biomarkers-dosage-hypothermia-arm","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3896316","moleculeType":"Small molecule","molecularWeight":"654.59"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The 'Hypothermia Arm' refers to a study cohort receiving therapeutic hypothermia as an intervention, with inflammatory biomarkers being measured as outcome variables to assess the anti-inflammatory effects of temperature reduction. This is a clinical trial design element rather than a pharmaceutical agent with a specific molecular mechanism of action.","oneSentence":"This is a clinical trial arm measuring inflammatory biomarkers in hypothermia-treated patients, not a drug with a defined pharmacological mechanism.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:15:59.236Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Therapeutic hypothermia in acute conditions (likely cardiac arrest, traumatic brain injury, or stroke based on typical hypothermia trial designs)"}]},"trialDetails":[{"nctId":"NCT02711098","phase":"PHASE3","title":"IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.","status":"COMPLETED","sponsor":"Centre Hospitalier Departemental Vendee","startDate":"2016-03","conditions":"Cardiac Arrest","enrollment":116}],"_emaApprovals":[],"_faersSignals":[{"count":9751,"reaction":"HYPOTHERMIA"},{"count":3090,"reaction":"HYPOTENSION"},{"count":2423,"reaction":"OFF LABEL USE"},{"count":2378,"reaction":"NAUSEA"},{"count":2318,"reaction":"ACUTE KIDNEY INJURY"},{"count":2272,"reaction":"DRUG INEFFECTIVE"},{"count":2213,"reaction":"DIARRHOEA"},{"count":2001,"reaction":"VOMITING"},{"count":1988,"reaction":"COMPLICATION ASSOCIATED WITH DEVICE"},{"count":1876,"reaction":"FATIGUE"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Inflammatory biomarkers dosage \"Hypothermia Arm\"","genericName":"Inflammatory biomarkers dosage \"Hypothermia Arm\"","companyName":"Centre Hospitalier Departemental Vendee","companyId":"centre-hospitalier-departemental-vendee","modality":"Biologic","firstApprovalDate":"","aiSummary":"This is a clinical trial arm measuring inflammatory biomarkers in hypothermia-treated patients, not a drug with a defined pharmacological mechanism. Used for Therapeutic hypothermia in acute conditions (likely cardiac arrest, traumatic brain injury, or stroke based on typical hypothermia trial designs).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}